Chinese Peptide Company
About Chinese Peptide Company
Categories
-
CN
-
2015On CPHI since
-
500 - 999Employees
Company types
Meet us at
CPHI & PMEC China 2024
Shanghai New International Expo Center
19 - 21 June 2024
CPHI Korea 2024
COEX, Seoul, Korea
27 - 29 August 2024
Products from Chinese Peptide Company (5)
-
Product Semaglutide
H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEAc-AEEAc-γ-Glu-carboxyheptadecanoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH (acetate salt) -
Product Leuprolide
Leuprolide sequence: pGlu-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt -
Product Linaclotide
[9-L-tyrosine]heat-stable enterotoxin (Escherichia coli)-(6-19)-peptide -
Product Teduglutide
H-His-Gly-Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Ala-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp-OH -
Product Difelikefallin
D-Phe-D-Phe-D-Leu-D-Lys-[γ-(4-N-piperidinyl)amino
Chinese Peptide Company Resources (1)
-
News CPC’s GMP Manufacturing Facility Passes German Inspection
Chinese Peptide Company, a public Hangzhou-based CDMO (Stock Symbol: 002390) is pleased to announce that our GMP manufacturing facility has successfully passed its inspection by the competent authority of Germany as an“active substance manufacturer that has been inspected in accordance with Art. 111 (1) Directive 2001/83/EC transposed in the following national legislation: Sect 64 para 1 Arzneimittelgesetz (German Drug Law).
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance